Lupin Pharmaceuticals Inc. recalls Liraglutide Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of particulate matter: a white thread-like structure in the cartridge
- Products
-
- Liraglutide Injection
- Company
- Lupin Pharmaceuticals Inc.
- Where it was sold
-
Nationwide within U.S
Nationwide
- Units affected
- 217,621 pen injectors
- About this recall
- Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.